IperionX Limited Sponsored ADR (NASDAQ:IPX) Given Consensus Rating of “Moderate Buy” by Analysts

IperionX Limited Sponsored ADR (NASDAQ:IPX) has earned a consensus recommendation of “Moderate Buy” from the six research firms that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation and five have given a buy recommendation to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $55.3333.

A number of research firms have recently issued reports on IPX. B. Riley Financial reduced their price target on shares of IperionX from $58.00 to $52.00 and set a “buy” rating for the company in a research report on Friday, March 13th. BTIG Research began coverage on shares of IperionX in a research report on Friday, March 27th. They issued a “buy” rating and a $40.00 price target for the company. Weiss Ratings reissued a “sell (e+)” rating on shares of IperionX in a research report on Tuesday, April 21st. Finally, Alliance Global Partners reissued a “buy” rating on shares of IperionX in a research report on Tuesday, April 28th.

Insider Buying and Selling

In other news, Chairman Todd Hannigan acquired 260,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 29th. The shares were purchased at an average price of $4.20 per share, for a total transaction of $1,092,000.00. Following the completion of the acquisition, the chairman owned 26,108,334 shares of the company’s stock, valued at approximately $109,655,002.80. This represents a 1.01% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Anastasios Arima acquired 110,000 shares of the company’s stock in a transaction that occurred on Tuesday, April 28th. The stock was purchased at an average price of $4.49 per share, for a total transaction of $493,900.00. Following the acquisition, the chief executive officer directly owned 12,316,782 shares of the company’s stock, valued at $55,302,351.18. The trade was a 0.90% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased 590,000 shares of company stock worth $2,571,500 in the last 90 days.

Hedge Funds Weigh In On IperionX

A number of hedge funds have recently added to or reduced their stakes in IPX. Van ECK Associates Corp acquired a new position in IperionX during the third quarter valued at approximately $40,997,000. Jones Financial Companies Lllp acquired a new position in IperionX during the third quarter valued at approximately $36,000. Vanguard Personalized Indexing Management LLC acquired a new position in IperionX during the third quarter valued at approximately $297,000. Verition Fund Management LLC acquired a new position in IperionX during the fourth quarter valued at approximately $314,000. Finally, XTX Topco Ltd acquired a new position in IperionX during the fourth quarter valued at approximately $302,000. Institutional investors and hedge funds own 2.76% of the company’s stock.

IperionX Stock Up 4.1%

IPX stock opened at $37.62 on Friday. The company has a quick ratio of 4.00, a current ratio of 4.03 and a debt-to-equity ratio of 0.03. IperionX has a one year low of $21.66 and a one year high of $61.45. The firm has a 50-day moving average of $31.62 and a two-hundred day moving average of $37.77.

IperionX (NASDAQ:IPX) last posted its quarterly earnings data on Saturday, January 31st. The company reported ($0.50) EPS for the quarter. On average, research analysts expect that IperionX will post -0.12 EPS for the current year.

About IperionX

IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.

At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.